🔍

HERANBA - Heranba Inds

📊 NSE: HERANBA 🏢 Pesticides / Agrochemicals - Indian 📅 Last Updated: 12/13/2025 22:53

📢 Recent Corporate Announcements

IBC Insolvency Application Filed Against Heranba Subsidiary Over Rs 93.90 Lakh Claim

🔵 WATCH ⭐ 6/10

LEGAL 📅 27 Feb 2026, 04:13 PM

Haresh Petrochem Private Limited has filed an insolvency petition under the IBC against Heranba Organics Private Limited, a 100% subsidiary of Heranba Industries. The initial claim was approximately Rs 1.70 Crores, which has been reduced to an outstanding balance of Rs 93.90 Lakhs following part payments. The company states the remaining balance is withheld due to quality disputes regarding the supplied goods. Management expects to settle the matter amicably outside the NCLT framework once the quality issues are addressed.

Insolvency application filed under Section 9 of IBC against 100% subsidiary Heranba Organics.
Total claim amount reduced from Rs 1.70 Crores to an outstanding balance of Rs 93.90 Lakhs.
Payment withheld by the subsidiary due to unresolved quality issues with the petitioner's supplies.
Management expects an out-of-court settlement and does not anticipate long-term material impact.

💡 Monitor the progress of the NCLT proceedings to ensure the settlement is reached as planned. While the claim amount is small, any escalation in insolvency proceedings for a subsidiary requires caution.

Heranba Q3: Consolidated Net Loss Widens to ₹23.29 Cr; Standalone Profit at ₹9.32 Cr

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 11 Feb 2026, 07:41 PM

Heranba Industries reported a weak set of consolidated numbers for Q3 FY26, with the net loss widening to ₹23.29 crore from a loss of ₹10.37 crore in the same quarter last year. Consolidated revenue from operations declined to ₹305.17 crore, down from ₹341.29 crore year-on-year. While standalone operations turned profitable at ₹9.32 crore compared to a loss last year, the consolidated performance was dragged down by higher finance costs and depreciation. The company also announced the appointment of ZMAS and Associates as the new Internal Auditor.

Consolidated revenue from operations fell to ₹305.17 crore in Q3 FY26 from ₹341.29 crore in Q3 FY25.
Consolidated net loss widened significantly to ₹23.29 crore versus a loss of ₹10.37 crore YoY.
Standalone profit stood at ₹9.32 crore, a recovery from a standalone loss of ₹9.12 crore in the previous year's quarter.
Consolidated finance costs doubled to ₹12.39 crore from ₹6.15 crore in the year-ago period.
Consolidated depreciation and amortisation expenses rose sharply to ₹25.67 crore from ₹14.03 crore YoY.

💡 Investors should exercise caution as widening consolidated losses and rising finance costs indicate significant pressure on the bottom line. The divergence between standalone profit and consolidated loss suggests underperformance in subsidiary operations that requires further scrutiny.

Heranba Industries Appoints ZMAS and Associates as Internal Auditor for Tenure Ending March 2027

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Feb 2026, 06:35 PM

Heranba Industries Limited has appointed ZMAS and Associates, Chartered Accountants, as its Internal Auditor. The appointment was approved by the Board of Directors on February 11, 2026, and covers the period from January 01, 2026, to March 31, 2027. This is a standard regulatory compliance measure under SEBI Listing Regulations to ensure internal financial controls. The firm, established in 2013, will be responsible for auditing the company's internal processes and governance frameworks.

Appointment of ZMAS and Associates (Firm Registration No. 136783W) as Internal Auditor.
The audit tenure is effective from January 01, 2026, through March 31, 2027.
Board approval for the appointment was granted during the meeting held on February 11, 2026.
The appointment complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 This is a routine administrative update with no direct impact on stock valuation; no specific action is required from investors. Continue to monitor the company's core business performance and quarterly earnings.

Heranba Q3 Results: Standalone Profit of ₹9.32 Cr; Consolidated Net Loss Widens to ₹23.29 Cr

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 11 Feb 2026, 06:13 PM

Heranba Industries reported a mixed Q3 FY26, with standalone operations turning profitable at ₹9.32 crore despite a 9.4% YoY revenue dip to ₹306.55 crore. However, the consolidated picture is concerning as net losses widened to ₹23.29 crore from ₹10.37 crore YoY. This deterioration is largely driven by a sharp spike in consolidated depreciation (₹25.67 crore vs ₹14.03 crore) and finance costs (₹12.39 crore vs ₹6.15 crore). The company also announced the appointment of ZMAS and Associates as internal auditors.

Standalone Net Profit of ₹9.32 crore vs a loss of ₹9.12 crore in Q3 FY25.
Consolidated Net Loss widened significantly to ₹23.29 crore from ₹10.37 crore YoY.
Consolidated Finance Costs surged 101% YoY to ₹12.39 crore.
Consolidated Depreciation and Amortization increased by 83% YoY to ₹25.67 crore.
Nine-month consolidated revenue showed growth at ₹1,235.58 crore vs ₹1,074.96 crore YoY.

💡 The widening consolidated loss despite standalone profitability suggests significant drag from subsidiaries or new capital expenditures not yet yielding returns. Investors should wait for management commentary on margin recovery and debt levels before taking new positions.

Heranba Subsidiary to Incorporate UAE Unit with INR 2 Crore Initial Investment

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 14 Jan 2026, 03:19 PM

Heranba Industries Limited has announced that its wholly-owned subsidiary, Mikusu India Private Limited, will establish a new 100% subsidiary in the United Arab Emirates. The new entity will focus on the agro-chemical business, specifically pesticides, insecticides, and herbicides. An initial cash investment of up to INR 2.00 crores is planned for this expansion. This strategic move aims to enhance the company's global footprint and distribution capabilities in the Middle East.

Board of Mikusu India Private Limited approved the 100% WOS in UAE on January 14, 2026.
Proposed initial investment in the UAE subsidiary is up to INR 2.00 crores in cash.
The entity will deal in chemical products including fungicides, weedicides, and pesticides.
RBI approval will be required for the remittance of Outward Direct Investment (ODI) post-inception.

💡 Investors should view this as a positive step toward international market penetration. Monitor the progress of the UAE subsidiary's incorporation and its eventual contribution to the company's export revenue.

Heranba Industries Reports 100% Demat Holding for Quarter Ended December 31, 2025

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 09 Jan 2026, 06:44 PM

Heranba Industries has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar, Bigshare Services, confirmed that no requests for dematerialization or rematerialization were received during the quarter ended December 31, 2025. Significantly, the Registrar noted that the entire shareholding of the company is already maintained in dematerialized form. This is a standard regulatory filing confirming the integrity of the company's share records.

Compliance certificate issued for the quarter ended December 31, 2025.
Registrar confirms that 100% of the company's shares are held in demat form.
Zero requests for dematerialization or rematerialization were processed during the period.
The filing follows the SEBI (Depositories and Participants) Regulations, 2018 requirements.

💡 No action is required from investors as this is a routine administrative filing. Continue to monitor the company's operational performance and upcoming quarterly financial results.

Heranba Industries to Close Trading Window from Jan 1, 2026, for Q3 FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Dec 2025, 03:51 PM

Heranba Industries Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI insider trading regulations. This closure is ahead of the declaration of the company's financial results for the quarter ended December 31, 2025. The window will remain closed for all designated persons and their immediate relatives until 48 hours after the results are made public. The specific date for the board meeting to approve these results will be announced at a later date.

Trading window closure begins on January 1, 2026.
Closure is related to the financial results for the quarter ended December 31, 2025.
Window will reopen 48 hours after the official declaration of financial results.
Restriction applies to all designated persons and connected individuals under SEBI PIT Regulations.

💡 This is a routine regulatory filing with no impact on company fundamentals; investors should monitor for the upcoming Q3 FY26 earnings date.

View All HERANBA Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total consolidated segment revenue for H1 FY26 reached INR 974.14 Cr, representing a 32.77% growth compared to INR 733.67 Cr in H1 FY25. A major business segment contributed INR 255.30 Cr, or 26.21% of total revenue, during H1 FY26.

Geographic Revenue Split

Export revenue contribution has moderated from 45% in FY23 to approximately 28-30% in FY25 due to global demand slowdown. Domestic revenue is supported by a pan-India network of 9,500+ dealers and 21+ depots.

Profitability Margins

Net profit margins are projected to stabilize at 5-6% in the next fiscal year. Consolidated Profit Before Tax (PBT) for H1 FY26 was INR 18.86 Cr, a 71.67% decline from INR 66.57 Cr in H1 FY25, impacted by a 74% increase in depreciation and a 127% rise in interest costs.

EBITDA Margin

EBITDA margins were suppressed at 5.4% for 9M FY25 due to lower product realizations and macro headwinds. Management targets a recovery to 12-14% EBITDA margin for the next fiscal year.

Capital Expenditure

Property, Plant, and Equipment (PPE) increased to INR 730.59 Cr as of September 30, 2025, from INR 662.34 Cr in March 2025. Significant investments are focused on the Sarigam Phase 2 and Saykha facilities.

Credit Rating & Borrowing

The company maintains a 'CRISIL A/Stable' rating (outlook revised from Positive) and 'CRISIL A1' for short-term facilities. Gearing remains low at 0.07 times, though interest expenses rose to INR 23.88 Cr in H1 FY26 from INR 10.49 Cr YoY.

⚙️ Operational Drivers

Raw Materials

Key raw materials include chemical intermediates for Technicals, Formulations, and Intermediates, which constitute the bulk of the 350+ products commercialized.

Import Sources

Not explicitly disclosed, but the company exports to 65+ countries across Asia, Africa, Middle East, and Southeast Asia, suggesting global sourcing and distribution links.

Capacity Expansion

Sarigam Phase 1 started commercial production in Q2 FY25. Sarigam Phase 2 and the Saykha facility are both expected to commence commercial production by the end of Q4 FY25.

Raw Material Costs

Raw material costs are impacted by lower realizations in the technical business. Provision for doubtful receivables increased to INR 8.26 Cr in H1 FY26 from INR 0.65 Cr YoY, reflecting credit environment challenges.

Manufacturing Efficiency

Manufacturing efficiency is currently impacted by lower realizations and the transitionary phase of new CAPEX; depreciation rose 74% YoY to INR 46.99 Cr as new assets were capitalized.

Logistics & Distribution

Distribution is handled through a network of 9,500+ dealers, supporting domestic revenue growth despite international headwinds.

📈 Strategic Growth

Expected Growth Rate

10.50%

Growth Strategy

Growth will be driven by operationalizing Sarigam Phase 2 and Saykha facilities by Q4 FY25, adding new product registrations, and expanding the customer base. The company aims to leverage its integrated 'Technicals to Formulations' model to capture market share as prices bottom out.

Products & Services

Agrochemical Technicals, Formulations, and Intermediates, including Synthetic Pyrethroids and branded domestic formulations.

Brand Portfolio

Heranba, Mikusu India, Daikaffil Chemicals.

New Products/Services

The company is looking to add new product registrations to drive the 'next wave of growth' following the completion of current CAPEX cycles.

Market Expansion

Expansion into 65+ countries and strengthening the domestic presence through 9,500+ dealers and new manufacturing hubs in Saykha and Sarigam.

Market Share & Ranking

Heranba is one of the leading players in the Indian agrochemicals industry with a diversified product mix.

Strategic Alliances

The group includes subsidiaries Mikusu India Private Limited, Heranba Organics Private Limited, and step-down subsidiary Daikaffil Chemicals India Limited.

🌍 External Factors

Industry Trends

The agrochemical industry is currently in a 'transitionary year' characterized by price bottoming and inventory destocking. Future growth is expected from integrated players with strong registration pipelines.

Competitive Landscape

Competes with other large-scale agrochemical manufacturers in both the technical export market and the domestic branded formulation market.

Competitive Moat

The moat is built on integrated operations (Technicals to Formulations), a massive network of 9,500+ dealers, and a portfolio of 350+ commercialized products, which are difficult for new entrants to replicate quickly.

Macro Economic Sensitivity

Highly sensitive to global agrochemical demand cycles and domestic monsoon patterns affecting the formulation business.

Consumer Behavior

Shift toward branded formulations in the domestic market is supporting revenue, while international B2B customers are currently focused on inventory destocking.

Geopolitical Risks

Challenging global macros and trade conditions have already reduced export revenue share by approximately 15 percentage points since FY23.

⚖️ Regulatory & Governance

Industry Regulations

Operations are governed by SEBI (LODR) Regulations and agrochemical manufacturing standards, including CIB&RC registrations for new products.

Environmental Compliance

Operations are subject to pollution control norms at GIDC Vapi, Sarigam, and Saykha; no specific ESG cost figures were provided.

Taxation Policy Impact

The company follows Indian Accounting Standards (Ind AS); specific tax rate impacts were not detailed beyond standard corporate tax applications.

Legal Contingencies

Auditors reported no matters causing belief that financial results have not disclosed required information under Regulation 33 of the Listing Regulations.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty is the timeline for the recovery of international demand, which could keep EBITDA margins suppressed below the 12-14% target if destocking persists.

Geographic Concentration Risk

Approximately 70% of revenue is now domestic, increasing sensitivity to Indian agricultural cycles, while 30% remains exposed to 65+ international markets.